These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 29843223)
21. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HNF1A-AS1 up-regulation in non-small cell lung cancer correlates to poor survival. Ma YF; Liang T; Li CR; Li YJ; Jin S; Liu Y Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4858-4863. PubMed ID: 27981551 [TBL] [Abstract][Full Text] [Related]
24. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value. Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer. Qian B; Wang X; Mao C; Jiang Y; Shi Y; Chen L; Liu S; Wang B; Pan S; Tao Y; Shi H Thorac Cancer; 2018 May; 9(5):589-597. PubMed ID: 29532622 [TBL] [Abstract][Full Text] [Related]
26. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484 [No Abstract] [Full Text] [Related]
28. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer. Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding nature brain-derived neurotrophic factor antisense is associated with poor prognosis and functional regulation in non-small cell lung caner. Shen M; Xu Z; Jiang K; Xu W; Chen Y; Xu Z Tumour Biol; 2017 May; 39(5):1010428317695948. PubMed ID: 28459374 [TBL] [Abstract][Full Text] [Related]
30. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker. Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045 [TBL] [Abstract][Full Text] [Related]
31. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. Liu L; Qu W; Zhong Z Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272 [TBL] [Abstract][Full Text] [Related]
32. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer. Yan B; Zhang W; Mao XW; Jiang LY Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database. Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients. Tian FM; Meng FQ; Wang XB Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5126-5131. PubMed ID: 28051258 [TBL] [Abstract][Full Text] [Related]
35. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer. Gharabaghi MA Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839 [TBL] [Abstract][Full Text] [Related]
37. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Wang T; Liu X; Tian Q; Liang T; Chang P Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485 [TBL] [Abstract][Full Text] [Related]
38. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916 [TBL] [Abstract][Full Text] [Related]
40. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer. Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]